Brightlands Venture Partners, a Netherlands-based venture capital firm, has held the first closing of its fourth fund at €45m ($m) including corporate commitments from DSM and Rabo.
Alongside chemicals company DSM and bank Rabo as limited partners in BVP Fund IV are the Dutch province of Limburg and its regional development agency, LIOF. In addition, €10m has been committed by the Netherlands Enterprise Agency (RVO) for investments in the renewable chemistry space.
Brightlands will invest in cleantech and health startups and scaleups in the Netherlands, Belgium and North Rhine Westphalia. Its prior deals include QC Polymers (mechanical recycling of commodity plastics), Ioniqa Technologies (chemical upcycling of PET), Black Bear Carbon and Fuenix (pyrolysis of used tyres and of mixed plastic waste), Neuroplast (treatment of paraplegia), Triplemed (aortic aneurysmas) and Matisse Pharmaceuticals (sepsis).
Casper Bruens, managing partner of Brightlands, which also manages Chemelot Ventures, Brightlands Agrifood Fund and Limburg Ventures, said: “The fund will be open to additional professional investors who want to join us to make more impact. Brightlands means renewable chemistry, regenerative medicine, agrifood and related digital technologies, areas where such impact is most needed.”
Casper picture from LinkedIn
